Response to Office Action

ENDO

Endo Pharmaceuticals Inc.

Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88346651
LAW OFFICE ASSIGNED LAW OFFICE 115
MARK SECTION
MARK http://uspto.report/TM/88346651/mark.png
LITERAL ELEMENT ENDO
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
EVIDENCE SECTION
        EVIDENCE FILE NAME(S)
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._endo_response.pdf
       CONVERTED PDF FILE(S)
       (13 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0002.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0003.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0004.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0005.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0006.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0007.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0008.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0009.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0010.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0011.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0012.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0013.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0014.JPG
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._Exhibit_A.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0015.JPG
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._Exhibit_B.pdf
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0016.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0017.JPG
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._Exhibit_C.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0018.JPG
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._Exhibit_D.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0019.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0020.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0021.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0022.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0023.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0024.JPG
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._Exhibit_E.pdf
       CONVERTED PDF FILE(S)
       (14 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0025.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0026.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0027.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0028.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0029.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0030.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0031.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0032.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0033.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0034.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0035.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0036.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0037.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0038.JPG
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._Exhibit_F.pdf
       CONVERTED PDF FILE(S)
       (4 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0039.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0040.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0041.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0042.JPG
       ORIGINAL PDF FILE evi_3898229178-20191016153048499953_._Exhibit_G.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0043.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0044.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\883\466\88346651\xml6\ROA0045.JPG
DESCRIPTION OF EVIDENCE FILE Exhibit A - website screenshots Exhibit B - website screenshots Exhibit C - website screenshots Exhibit D - website screenshots Exhibit E - copies of registrations Exhibit F - website screenshots, as well as for website screenshots of the most and least expensive supplements designated on Worthly's list for comparison Exhibit G - website screenshots
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 005
DESCRIPTION
drug substances, namely, enzymes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; nutritional and dietary supplements; vitamins and mineral supplements; food supplements
FILING BASIS Section 1(b)
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 005
TRACKED TEXT DESCRIPTION
drug substances, namely, enzymes; drug substances, namely, enzymes applied by injection available only via prescription; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for the treatment of cellulite applied by injection and available only via prescription.; pharmaceutical preparations for skin care; nutritional and dietary supplements; vitamins and mineral supplements; food supplements
FINAL DESCRIPTION
drug substances, namely, enzymes applied by injection available only via prescription; pharmaceutical preparations for the treatment of cellulite applied by injection and available only via prescription.
FILING BASIS Section 1(b)
ATTORNEY SECTION (current)
NAME Camille M. Miller
ATTORNEY BAR MEMBERSHIP NUMBER NOT SPECIFIED
YEAR OF ADMISSION NOT SPECIFIED
U.S. STATE/ COMMONWEALTH/ TERRITORY NOT SPECIFIED
FIRM NAME COZEN O'CONNOR
INTERNAL ADDRESS SUITE 2800
STREET 1650 MARKET STREET
CITY PHILADELPHIA
STATE Pennsylvania
POSTAL CODE 19103
COUNTRY US
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER ENDO-
ATTORNEY SECTION (proposed)
NAME Camille M. Miller
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS Suite 2800
STREET 1650 Market Street
CITY Philadelphia
STATE Pennsylvania
POSTAL CODE 19103
COUNTRY United States
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER ENDO-
OTHER APPOINTED ATTORNEY Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin Gibbs
CORRESPONDENCE SECTION (current)
NAME CAMILLE M. MILLER
FIRM NAME COZEN O'CONNOR
INTERNAL ADDRESS SUITE 2800
STREET 1650 MARKET STREET
CITY PHILADELPHIA
STATE Pennsylvania
POSTAL CODE 19103
COUNTRY US
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER ENDO-
CORRESPONDENCE SECTION (proposed)
NAME Camille M. Miller
FIRM NAME Cozen O'Connor
INTERNAL ADDRESS Suite 2800
STREET 1650 Market Street
CITY Philadelphia
STATE Pennsylvania
POSTAL CODE 19103
COUNTRY United States
PHONE 215-665-7273
FAX 2157012273
EMAIL cmiller@cozen.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
DOCKET/REFERENCE NUMBER ENDO-
SIGNATURE SECTION
RESPONSE SIGNATURE /Camille M. Miller/
SIGNATORY'S NAME Camille M. Miller
SIGNATORY'S POSITION attorney
SIGNATORY'S PHONE NUMBER 2156657273
DATE SIGNED 10/16/2019
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Wed Oct 16 15:52:00 EDT 2019
TEAS STAMP USPTO/ROA-XX.XX.XXX.XXX-2
0191016155200216861-88346
651-61059edacbbe8dfe4948a
42c8f0746482b67bf337f4036
8df566f5fad38bccf34-N/A-N
/A-20191016153048499953



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 88346651 ENDO(Standard Characters, see http://uspto.report/TM/88346651/mark.png) has been amended as follows:

EVIDENCE
Evidence in the nature of Exhibit A - website screenshots Exhibit B - website screenshots Exhibit C - website screenshots Exhibit D - website screenshots Exhibit E - copies of registrations Exhibit F - website screenshots, as well as for website screenshots of the most and least expensive supplements designated on Worthly's list for comparison Exhibit G - website screenshots has been attached.
Original PDF file:
evi_3898229178-20191016153048499953_._endo_response.pdf
Converted PDF file(s) ( 13 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Evidence-7
Evidence-8
Evidence-9
Evidence-10
Evidence-11
Evidence-12
Evidence-13
Original PDF file:
evi_3898229178-20191016153048499953_._Exhibit_A.pdf
Converted PDF file(s) ( 1 page)
Evidence-1
Original PDF file:
evi_3898229178-20191016153048499953_._Exhibit_B.pdf
Converted PDF file(s) ( 2 pages)
Evidence-1
Evidence-2
Original PDF file:
evi_3898229178-20191016153048499953_._Exhibit_C.pdf
Converted PDF file(s) ( 1 page)
Evidence-1
Original PDF file:
evi_3898229178-20191016153048499953_._Exhibit_D.pdf
Converted PDF file(s) ( 6 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Original PDF file:
evi_3898229178-20191016153048499953_._Exhibit_E.pdf
Converted PDF file(s) ( 14 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Evidence-7
Evidence-8
Evidence-9
Evidence-10
Evidence-11
Evidence-12
Evidence-13
Evidence-14
Original PDF file:
evi_3898229178-20191016153048499953_._Exhibit_F.pdf
Converted PDF file(s) ( 4 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Original PDF file:
evi_3898229178-20191016153048499953_._Exhibit_G.pdf
Converted PDF file(s) ( 3 pages)
Evidence-1
Evidence-2
Evidence-3

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for drug substances, namely, enzymes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; nutritional and dietary supplements; vitamins and mineral supplements; food supplements
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Proposed:
Tracked Text Description: drug substances, namely, enzymes; drug substances, namely, enzymes applied by injection available only via prescription; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for the treatment of cellulite applied by injection and available only via prescription.; pharmaceutical preparations for skin care; nutritional and dietary supplements; vitamins and mineral supplements; food supplementsClass 005 for drug substances, namely, enzymes applied by injection available only via prescription; pharmaceutical preparations for the treatment of cellulite applied by injection and available only via prescription.
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

The applicant's current attorney information: Camille M. Miller. Camille M. Miller of COZEN O'CONNOR, is located at

      SUITE 2800
      1650 MARKET STREET
      PHILADELPHIA, Pennsylvania 19103
      US
The docket/reference number is ENDO-.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

The applicants proposed attorney information: Camille M. Miller. Other appointed attorneys are Melanie A. Miller, J. Trevor Cloak, Chanel L. Lattimer, Brianne L. Polito, Ashley Kessler, Mayura Noordyke, Kevin Gibbs. Camille M. Miller of Cozen O'Connor, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      Suite 2800
      1650 Market Street
      Philadelphia, Pennsylvania 19103
      United States
The docket/reference number is ENDO-.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

Camille M. Miller submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current correspondence information: CAMILLE M. MILLER. CAMILLE M. MILLER of COZEN O'CONNOR, is located at

      SUITE 2800
      1650 MARKET STREET
      PHILADELPHIA, Pennsylvania 19103
      US
The docket/reference number is ENDO-.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

The applicants proposed correspondence information: Camille M. Miller. Camille M. Miller of Cozen O'Connor, is located at

      Suite 2800
      1650 Market Street
      Philadelphia, Pennsylvania 19103
      United States
The docket/reference number is ENDO-.

The phone number is 215-665-7273.

The fax number is 2157012273.

The email address is cmiller@cozen.com

SIGNATURE(S)
Response Signature
Signature: /Camille M. Miller/     Date: 10/16/2019
Signatory's Name: Camille M. Miller
Signatory's Position: attorney

Signatory's Phone Number: 2156657273

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    CAMILLE M. MILLER
   COZEN O'CONNOR
   SUITE 2800
   1650 MARKET STREET
   PHILADELPHIA, Pennsylvania 19103
Mailing Address:    Camille M. Miller
   Cozen O'Connor
   Suite 2800
   1650 Market Street
   Philadelphia, Pennsylvania 19103
        
Serial Number: 88346651
Internet Transmission Date: Wed Oct 16 15:52:00 EDT 2019
TEAS Stamp: USPTO/ROA-XX.XX.XXX.XXX-2019101615520021
6861-88346651-61059edacbbe8dfe4948a42c8f
0746482b67bf337f40368df566f5fad38bccf34-
N/A-N/A-20191016153048499953


Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]

Response to Office Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed